These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8594669)

  • 61. High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon.
    Simo G; Asonganyi T; Nkinin SW; Njiokou F; Herder S
    Vet Parasitol; 2006 Jun; 139(1-3):57-66. PubMed ID: 16567049
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
    Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
    Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?
    Büscher P; Deborggraeve S
    Expert Rev Mol Diagn; 2015 May; 15(5):607-15. PubMed ID: 25786994
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Interpretation of the CATT (Card Agglutination Trypanosomiasis Test) in the screening for human trypanosomiasis due to Trypanosoma brucei gambiense].
    Penchenier L; Jannin J; Moulia-Pelat JP; Elfassi de la Baume F; Fadat G; Chanfreau B; Eozenou P
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):221-8. PubMed ID: 1958107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemotherapy of African sleeping sickness. II. Chemotherapy of experimental Trypanosoma gambiense and Trypanosoma rhodesiense infections in mice (Mus musculus) with a new antibiotic, amphomycin.
    PACKCHANIAN A
    Antibiot Chemother (Northfield); 1956 Dec; 6(12):684-91. PubMed ID: 24544152
    [No Abstract]   [Full Text] [Related]  

  • 66. Nitrofurazone therapy of Trypanosoma gambiense sleeping sickness in man.
    EVENS F; NIEMEGEERS K; PACKCHANIAN A
    Am J Trop Med Hyg; 1957 Jul; 6(4):665-78. PubMed ID: 13458672
    [No Abstract]   [Full Text] [Related]  

  • 67. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Loko L; Ethier L; Mpia B; Pépin J
    Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advances in sleeping sickness therapy.
    Van Nieuwenhove S
    Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trypanosoma brucei gambiense trypanosomiasis in Terego county, northern Uganda, 1996: a lot quality assurance sampling survey.
    Hutin YJ; Legros D; Owini V; Brown V; Lee E; Mbulamberi D; Paquet C
    Am J Trop Med Hyg; 2004 Apr; 70(4):390-4. PubMed ID: 15100452
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The epidemiology and control of human African trypanosomiasis.
    Pépin J; Méda HA
    Adv Parasitol; 2001; 49():71-132. PubMed ID: 11461032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction.
    Kyambadde JW; Enyaru JC; Matovu E; Odiit M; Carasco JF
    Bull World Health Organ; 2000; 78(1):119-24. PubMed ID: 10686746
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness).
    Kennedy PG
    Lancet Neurol; 2013 Feb; 12(2):186-94. PubMed ID: 23260189
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sleeping sickness in the region of the town of Kinshasa: a retrospective analysis during the surveillance period 1996-2000].
    Ebeja AK; Lutumba P; Molisho D; Kegels G; Miaka mia Bilenge C; Boelaert M
    Trop Med Int Health; 2003 Oct; 8(10):949-55. PubMed ID: 14516307
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Spinal and cerebral fluids in sleeping sickness from Trypanosoma gambiense].
    NEUJEAN G
    Ann Soc Belg Med Trop (1920); 1950 Nov; 30(5):1125-1387. PubMed ID: 14811248
    [No Abstract]   [Full Text] [Related]  

  • 76. [Effect of penicillin in sleeping sickness (Trypanosoma gambiense)].
    PIRES FM
    An Inst Med Trop (Lisb); 1951 Mar; 8(1):65-81. PubMed ID: 14894799
    [No Abstract]   [Full Text] [Related]  

  • 77. Modelling timelines to elimination of sleeping sickness in the Democratic Republic of Congo, accounting for possible cryptic human and animal transmission.
    Crump RE; Aliee M; Sutherland SA; Huang CI; Crowley EH; Spencer SEF; Keeling MJ; Shampa C; Mwamba Miaka E; Rock KS
    Parasit Vectors; 2024 Aug; 17(1):332. PubMed ID: 39123265
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The febrile response to treatment in Gambian sleeping sickness.
    Whittle HC; Pope HM
    Ann Trop Med Parasitol; 1972 Mar; 66(1):7-14. PubMed ID: 5021574
    [No Abstract]   [Full Text] [Related]  

  • 79. Chemotherapy of African sleeping sickness. I. Chemotherapy of experimental Trypanosoma gambiense infection in mice (Mus musculus) with nitrofurazone.
    PACKCHANIAN A
    Am J Trop Med Hyg; 1955 Jul; 4(4):705-11. PubMed ID: 13238726
    [No Abstract]   [Full Text] [Related]  

  • 80. Population genetics of Trypanosoma brucei in central Africa: taxonomic and epidemiological significance.
    Truc P; Tibayrenc M
    Parasitology; 1993 Feb; 106 ( Pt 2)():137-49. PubMed ID: 8095328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.